After helping to develop and test new mRNA technologies for COVID-19 vaccines, University of Maryland School of Medicine (UMSOM) researchers and scientists are turning their attention to utilizing this innovative technology ...
Apr 7, 2023
1
72
A protein that plays a critical role in helping malaria parasites infect red blood cells—known as apical membrane protein 1 (AMA1)—has been found to bind to more than one receptor on the surface of the cells.
Mar 3, 2023
0
5
A three-dose regimen of a whole-parasite vaccine against malaria—called Plasmodium falciparum sporozoite (PfSPZ) vaccine—demonstrated safety and efficacy when tested in adults living in Burkina Faso, West Africa, which ...
Jan 4, 2023
0
71
The coronavirus pandemic interrupted efforts to control malaria, resulting in 63,000 additional deaths and 13 million more infections globally over two years, according to a report from the World Health Organization published ...
Dec 8, 2022
1
38
Scientists from Sanaria Inc., and collaborators at multiple institutions published results in Nature reporting "In vitro production of infectious Plasmodium falciparum sporozoites."
Dec 7, 2022
0
15
Malaria is found in more than 90 countries around the world, causing 241 million cases and an estimated 627,000 deaths every year. Vaccines are one intervention that could help eliminate this deadly disease, yet a highly ...
Dec 1, 2022
0
103
The development of an effective vaccine for malaria has proved to be far more challenging than developing a vaccine to protect people from COVID-19. Several different COVID-19 vaccines were developed and approved for use ...
Oct 31, 2022
0
29
A vaccine candidate called R21 has been shown to be up to 80% effective at preventing malaria in young children, according to the latest trial results.
Sep 15, 2022
0
6
Researchers from the Walter Reed Army Institute of Research (WRAIR) report the malaria vaccine FMP013 antigen and ALFQ adjuvant combination appears safe and immunogenic for adults in the first-in-human evaluation results ...
Sep 14, 2022
0
39
Researchers from the University of Oxford and their partners have today reported new findings from their Phase 2b trial following the administration of a booster dose of the candidate malaria vaccine, R21/Matrix-M—which ...
Sep 11, 2022
0
5
